<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We reported the different clinical features between Japanese and German <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA) patients in FAB classification </plain></SENT>
<SENT sid="1" pm="."><plain>We re-analyzed the clinical features by WHO classification revised in 2008 </plain></SENT>
<SENT sid="2" pm="."><plain>The frequencies of refractory cytopenia with unilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (RCUD) and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>-unclassified (<z:e sem="disease" ids="C0854809" disease_type="Neoplastic Process" abbrv="">MDS-U</z:e>) with <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> in Japanese patients were higher than in German patients (p&lt;0.001) </plain></SENT>
<SENT sid="3" pm="."><plain>Refractory cytopenia with multilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> patients showed the most unfavorable prognosis in both countries </plain></SENT>
<SENT sid="4" pm="."><plain>The higher frequencies of <z:e sem="disease" ids="C0854809" disease_type="Neoplastic Process" abbrv="">MDS-U</z:e> with <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> and RCUD in Japanese patients may influence the different clinical characteristics between Japanese and German FAB-RA patients </plain></SENT>
</text></document>